Free Republic

PROVIDENCE, R.I. (WLNE) — President Joe Biden tested positive for Covid-19 once again, CNN reported Saturday. “His physician said he’s not experiencing any symptoms, but that he will isolate at the White House,” said CNN. The President Tweeted:Folks, today I tested positive for COVID again. This happens with a small minority of folks. I’ve got no symptoms but I am going to isolate for the safety of everyone around me. I’m still at work, and will be back on the road soon.— President Biden (@POTUS) July 30, 2022Biden tested positive more than a week ago a day after visiting Massachusetts.This...

Joe tested positive this morning

President Joe Biden has tested positive again for Covid-19, the White House said Saturday. His physician said he's not experiencing any symptoms, but that he will isolate at the White House. This is a breaking story and will be updated.

A recent New York Times/Siena College poll showing 64 percent of Democrats preferring a new standard-bearer in 2024 rocked the White House and the political landscape, but it should not have come as a big surprise. After all, President Joe Biden continues to fall short of the promises that drew many Democrats, including myself, to his candidacy in 2020: his pledge for a new strategy combatting Covid-19. Consider the Food and Drug Administration’s recent decision allowing pharmacists to play doctor and prescribe Pfizer’s anti-viral treatment Paxlovid, which Biden himself, having contracted Covid-19, is now taking. The agency claims this is...

President Biden’s physician stopped the commander-in-chief’s use of heart medications Thursday after he began to take Paxlovid to treat COVID-19, White House officials said — despite the fact that doing so elevates the risk of dangerous blood clots. Dr. Ashish Jha, the White House coronavirus coordinator, said at a press briefing that it’s “very standard” to discontinue the medications during a five-day regimen of the antiviral Paxlovid.

Story at a glance:The COVID-19 pandemic has been a real boon to Pfizer. Not only has it doubled Pfizer’s annual revenue, but it has also given the drugmaker unique weight in determining U.S. health policy — something that concerns even staunch vaccine-pushers like Dr. Paul Offit.Pfizer’s revenue in 2021 was $81.3 billion — approximately double that of 2020 — and the COVID shot accounted for $36.78 billion of that.Pfizer’s COVID jab dominates 70% of the U.S. and European markets, and Paxlovid, its COVID drug, has become a standard treatment choice in hospitals. This despite findings showing the shot doesn’t prevent...

President Joe Biden has tested positive for Covid-19, the White House said Thursday. The president, who is fully vaccinated and has received two Covid booster shots, is experiencing “very mild symptoms,” press secretary Karine Jean-Pierre said in a statement.

Fauci took an antiviral COVID treatment. During the June 23 briefing, Fauci confirmed that he had finished his five-day treatment of Paxlovid, an oral antiviral pill developed by Pfizer and authorized by the Food and Drug Administration (FDA). After completing a round of Paxlovid, Fauci tested negative for COVID three days in a row, Forbes reported. But a rapid antigen test displayed a positive result on day four, with Fauci indicating he was experiencing a "Paxlovid rebound" and a resurgence of COVID symptoms. "Over the next day or so, I started to feel really poorly, much worse than in the...

On June 15, Dr. Anthony Fauci announced that he had tested positive for COVID-19. It was a long time coming since nearly everyone around him in the White House has tested positive at least once. In fact, the number of high-profile people with repeated infections is rising — former White House Press Secretary Jen Psaki, Canadian Prime Minister Justin Trudeau, and Prince Charles, to name a few. Of course, what they all had in common was every single COVID jab available to them.Fauci was no exception. When he provided an update on his condition during a conference call on June...

Fauci says he's taking 2nd course of Paxlovid after experiencing rebound with the antiviral treatment After testing positive for COVID-19 earlier this month, Dr. Anthony Fauci said Tuesday that he has joined a growing group of people experiencing a Paxlovid rebound, following treatment with Pfizer's antiviral. Fauci, 81, said that when he first tested positive two weeks ago, he had very minimal symptoms. However, when he began to feel worse, "given [his] age," he was prescribed Paxlovid.

Paxlovid According to a statement by the company, Pfizer has stopped COVID pill trial after the latest results showed that it did not reduce symptoms, hospitalizations and deaths. Pfizer has stated it will halt participation in a clinical trial for Paxlovid, its COVID-19 antiviral medication, for standard-risk COVID-19 patients after the most recent findings revealed the medication did not numerically greatly lower symptoms, hospitalizations, or fatalities. In more than 65 nations, including the United States, Paxlovid, a combination of the antivirals nirmatrelvir and ritonavir, is presently approved or authorized for conditional or emergency use in the treatment of COVID-19...

Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree. Paxlovid, which consists of two different antiviral drugs—nirmatrelvir and ritonavir—is currently approved or authorized for conditional or emergency use in more than 65 countries, including the United States, to treat COVID-19 patients at high risk of severe illness, including hospitalization or death. Pfizer said on June 14 that it will “cease enrollment into the EPIC-SR trial due to low rate of...

When the patient came back 10 days later, coughing repeatedly and complaining of headache, Davey Smith feared the worst. Smith had prescribed the patient Pfizer’s new antiviral pill, Paxlovid, on the previous visit, after a COVID-19 test came back positive. A resurgence of symptoms probably meant one thing, especially after Smith tested the patient and got another positive. “I was pretty sure it was resistance,” said Smith, an infectious disease physician at the University of California, San Diego. “I’m a virologist, I combat resistance all the time.”

The U.S. Food and Drug Administration (FDA) is investigating reports of relapses among people who took Pfizer’s COVID-19 pill. The FDA “is evaluating the reports of viral load rebound after completing paxlovid treatment and will share recommendations if appropriate,” an agency spokesperson told The Epoch Times in an email. In a recent preprint case report, Veterans Affairs researchers reported that a 71-year-old male who took the pill, also known as nirmatrelvir, experienced a “rapid and progressive reduction” in the viral load of SARS-CoV-2, the virus that causes COVID-19. But four days after completing the treatment course, there was a “surprising...

Harris tested positive for Covid-19 ahead of meetings at the White House Tuesday morning, and is not considered a close contact of President Joe Biden. Harris had been scheduled to receive her intelligence briefing at the White House alongside Biden, but tested positive on a rapid test and a PCR test ahead of that meeting. She did not participate in any events or meetings at the White House on Tuesday, according to a White House official. As part of her treatment, Harris has the covid antiviral pill, Pfizer’s Paxlovid. Under conditions of the Food and Drug Administration’s emergency use authorization...

People who took Pfizer’s COVID pill Paxlovid, reported that following the five-day treatment period, they would begin testing positive for Covid again and it has as a result failed in clinical trials.Paxlovid has been hailed as one of the gold standard Covid treatments in the United States, with President Joe Biden mentioning it at this year’s State of the Union speech.However, some people who took the drug to treat the virus have reported an unusual occurrence.The Pfizer-developed medicine is thought to be highly effective at averting hospitalization or death in people who have already been infected with the virus, but...

Vice President Kamala Harris has been prescribed and has taken Paxlovid, an antiviral pill used to treat COVID-19. Harris’s press secretary Kirsten Allen tweeted the announcement about the vice president’s treatment on Tuesday. It came just hours after it was announced that Harris, who is fully vaccinated and boosted, tested positive for COVID-19.

Some recipients of Paxlovid, an antiviral pill developed by Pfizer, are reporting Covid symptoms returning after finishing their course of the drug The drug was touted by President Joe Biden and collectively offered to all Americans at his 2022 State of the Union addressThere are multiple reports of people in the Boston area suddenly feeling sick and testing positive for Covid after the drug initially helped them get over the virusOne expert described it as 'cat and mouse', with the virus being able to return after the drug suppressing it cleared from a person's system Paxlovid has been deemed one...

Repurposed drugs that have been shown to prevent or treat COVID-19 may be prescribed by physicians, the Florida Department of Health said in its new COVID-19 guidance for health care practitioners.The guidance, published on Feb. 24, says that health care practitioners are encouraged to provide early treatment for COVID-19 patients with federally approved generic drugs that they find will work. That’s in addition to the outpatient treatments granted emergency authorization usage (EUA) for people at risk of developing a serious illness.“When recommending COVID-19 treatment options for patients’ individualized health care needs, physicians should exercise their individual clinical judgment and expertise...

OTTAWA — Health Canada has approved Paxlovid, Pfizer’s oral antiviral treatment for COVID-19 that has been touted as a way to ease pressure on health-care systems overburdened by rising case counts. According to an authorization posted on the regulator’s web page Monday morning, the treatment has been approved for adults with mild to moderate forms of the illness who are at high risk of developing more severe outcomes. Because safety and efficacy data was not submitted to Health Canada on the use of the drug on younger age groups, Paxlovid has not been approved for pediatric patients. The pill is...